Clinical trials · Grand Rapids, MI
Clear Cell Renal Cell Carcinoma clinical trials in Grand Rapids
We’re tracking 7 recruiting clear cell renal cell carcinoma studies with a site in or near Grand Rapids — including Phase 1, Phase 1/Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Grand Rapids
- NCT07300241RecruitingPhase 1
Study of NEO-811 for advanced kidney cancer
This trial tests a new drug called NEO-811 for people with advanced clear cell kidney cancer that has spread and can't be removed with surgery. The goal is to see if it helps when other treatments have stopped working or aren't an option.
Grand Rapids, MichiganAges 18 years+ - NCT04104776RecruitingPhase 1/Phase 2
Test drug tulmimetostat for advanced cancers and lymphomas
This early-phase study tests tulmimetostat (DZR123) to shrink or control advanced solid tumors and certain lymphomas, and it may also test a combination in some prostate cancer groups. If you qualify, you’ll receive the study drug and be monitored closely, including blood tests and a request for tumor tissue to look for biomarkers.
Grand Rapids, MichiganAges 18 years+ - NCT05059444Recruiting
Blood test to catch cancer early after treatment
This study looks for signs of cancer left in the body after treatment using a simple blood test (called a liquid biopsy). It aims to see if the test can catch cancer that might come back earlier than regular scans.
Grand Rapids, MichiganAges 18 years+ - NCT06242470RecruitingPhase 1
Study of MGC026 for advanced solid tumors
This trial tests a new drug called MGC026 that targets a protein called B7-H3 on cancer cells, aiming to shrink or slow different advanced solid tumors. It is an early-phase study to find the right dose and check safety.
Grand Rapids, MichiganAges 18 years+ - NCT06413680RecruitingPhase 1/Phase 2
Study of REGN10597 with or without cemiplimab for advanced solid tumors
This study tests a new drug called REGN10597, either alone or with cemiplimab, for people with advanced solid tumors (like melanoma or kidney cancer) that have not responded to standard treatments. The goal is to see if the combination can shrink tumors or slow their growth.
Grand Rapids, MichiganAges 18 years+ - NCT04510597RecruitingPhase 3
Immunotherapy plus surgery versus immunotherapy alone for kidney cancer
This study tests whether adding surgery to remove the kidney improves outcomes compared with continuing immunotherapy without surgery. It is for people with metastatic kidney cancer whose disease has not worsened after initial immunotherapy.
Grand Rapids, MichiganAges 18 years+ - NCT06661720RecruitingPhase 3
Tivozanib and pembrolizumab after kidney cancer surgery
This trial is testing if adding the targeted therapy tivozanib to the immunotherapy drug pembrolizumab (Keytruda) can help prevent kidney cancer from coming back after all known tumors have been removed by surgery.
Grand Rapids, MichiganAges 18 years+
Hear when a new Clear Cell Renal Cell Carcinoma trial opens near Grand Rapids, MI
We’ll email you when one opens near Grand Rapids, MI — at most once a week, no account needed, unsubscribe anytime.
Clear Cell Renal Cell Carcinoma trials in other cities
Where these studies are running near Grand Rapids
Institutions with a site for the recruiting clear cell renal cell carcinoma studies listed above.
- Cancer and Hematology Centers of Western Michigan - Norton Shores · 2 studies
- Trinity Health Grand Rapids Hospital · 2 studies
- Trinity Health Muskegon Hospital · 2 studies
- University of Michigan Health - West · 2 studies
- Cancer & Hematology Centers of Western Michigan
- Corewell Health Butterworth Hospital
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
- Corewell Health Helen DeVos Children's Hospital
What taking part in a clear cell renal cell carcinoma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting clear cell renal cell carcinoma studies in Michigan.
Common questions
- Are there clear cell renal cell carcinoma clinical trials near Grand Rapids?
- Yes. We're currently tracking 7 recruiting clear cell renal cell carcinoma studies with a site near Grand Rapids, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a clear cell renal cell carcinoma study near Grand Rapids?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Grand Rapids to take part?
- Not necessarily. These studies have a site near Grand Rapids, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a clear cell renal cell carcinoma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New clear cell renal cell carcinoma studies open near Grand Rapids regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.